Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimum Immunosuppression in Renal Transplant Recipients at High Risk of Developing New Onset Diabetes After Transplantation: A Multicenter, Prospective, Controlled and Randomized Trial.

NCT01002339 is registered in ClinicalTrials.gov with Armando Torres Ramírez as lead sponsor.

NCT NCT01002339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01002339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimum Immunosuppression in Renal Transplant Recipients at High Risk of Developing New Onset Diabetes After Transplantation: A Multicenter, Prospective, Controlled and Randomized Trial.
Lead sponsor
Armando Torres Ramírez
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2010
Completion date
June 30, 2015
Enrollment
134 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, adult-onset